19937 results for «»
19937 results
Scientific highlights, clinical trial updates and key learnings from EuroPCR 2024
17 May 2024 – From EuroPCR 2024
Davide Capodanno presents notable trial updates, coronary devices, and key takeaways from EuroPCR 2024. Highlights include the SOLVE-TAVI and IDEAL-LM trials at 5 years, BIOADAPTOR at 2 years, advancements in drug-coated balloons and DES, as well as insights from REC-CAGEFREE II, LANDMARK, and NOTION-2.
References
- SOLVE-TAVI: Feistritzer HJ, et al....
GENESIS-II study reveals promising 30-day results for the hydra self-expanding transcatheter aortic valve
16 May 2024
Personalised Vascular Care Award ceremony
16 May 2024 – From EuroPCR 2024
This session is the Personalised Vascular Care Award ceremony, sponsored by Abbott. The objectives and details of this session are not provided, as it is likely an event to recognize and celebrate achievements in the field of personalized vascular care.
INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes
03 Sep 2024
Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.
Author
REC-CAGEFREE I - Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of de novo coronary artery lesions
08 Sep 2024
Mirvat Alasnag provides her take on REC-CAGEFREE I, a multicenter, non-inferiority trial presented at the ESC Congress 2024 in London.
Author
Robotic-assisted transcatheter edge-to-edge repair with MitraClip G4
05 Jul 2024
This case report demonstrates, for the first time, the feasibility of mitral TEER with a robotic-assisted approach, using the Abbott MitraClip G4 system, potentially paving the way for future applications in structural heart and endovascular interventions.
Author
Author
Author
OCCUPI - Optical coherence tomography-guided coronary intervention in patients with complex lesions
03 Sep 2024
Alex Sticchi provides his take on the OCCUPI trial presented by Kim Byeong-Keuk at the ESC Congress 2024 in London.
Author
SENIOR-RITA - Older patients with non-ST segment elevation myocardial infarction randomised interventional treatment trial
02 Sep 2024
Mirvat Alasnag provides her take on the SENIOR-RITA trial, presented by Vijay Kunadian at the ESC Congress 2024 in London.
Author
EARTH-STEMI - Complete vs. culprit-only revascularisation in older STEMI patients
03 Sep 2024
Aaysha Cader interviews Gianluca Campo about the EARTH-STEMI trial he presented at ESC Congress 2024 in London.
This meta-analysis aimed to evaluate a large cohort of STEMI patients, predominantly comorbid, with a mean age of 79 and extended long-term follow-up. The key findings revealed that complete revascularisation reduced the...
Author
Author
SCOFF - Fasting or no fasting before cardiac catherisation procedures
03 Sep 2024
Aaysha Cader interviews David Ferreira about the SCOFF trial he presented at the ESC Congress 2024 in London.
Results showed that eating normally before minimally invasive heart procedures did not increase complications and improved patient satisfaction, suggesting a need to reconsider fasting guidelines.
Author
Author
Euro4C: who we are
19 Jun 2024
True to its core mission of serving the needs of each individual patient by helping the cardiovascular community share knowledge experience and practice, PCR has been welcoming and supporting communities’ initiatives all throughout its history + mot du president ...
Controlled ring expansion during aortic valve-in-valve: a proof-of-concept CT-scan analysis
24 Jun 2024
Analyze this EIJ image to see how surgical aortic bioprostheses with expandable ring technology can significantly enhance future ViV procedures.
How to deal with ilio-femoral tortuosity during TAVI procedure: the buddy wire technique to straighten the pathway
09 Sep 2024
Author
Author
Author
Flat-out success: TAVI in a patient with a horizontal aorta and large annulus
16 Oct 2024
Study the case of an 86-year-old male patient with progressive NYHA III dyspnoea, HTN, AF and previous stroke who presented with HF, LVEF 61 %, severe atrial dilatation, severe AS, mild MR and severely calcified tricuspid aortic valve with a large annulus suitable for transfemoral TAVI.
Author
Author
TAVI: a fascinating 20-year-long odyssey with a happy ending
10 Nov 2017
This new "disruptive" technology is among the most important medical breakthroughs to date. TAVI emerged in 2002 to profoundly alter the landscape of cardiovascular medicine.
#AictPCR 2025 Social Media Team
Khaled Almerri
Hadiya, Kuwait
Masahiko Asami
Tokyo, Japan
Fawaz Bardooli
Awali, Bahrain
Arnaud Bertrand
Montbonnot Saint Martin, France